Why a pet wellness plan is worth considering
Your pet isn't just an animal — they're part of the family. That's why their health and well-being are a top priority. Regular trips to the vet and vaccinations can help keep them happy and healthy, but those bills can pile up fast. A pet wellness plan can help you offset some of those routine costs and stay ahead of your pet's care needs.
Knowing how these plans work can help you decide if a wellness plan is a good fit for you and your furry friend.
Learn more: How does pet insurance work? A complete guide.
While pet insurance covers unexpected costs from accidents and illnesses, pet wellness plans help cover the expected costs of preventive care for your pet. They're usually offered as an add-on to an accident and illness pet insurance policy, but some companies — like Pumpkin pet insurance — offer standalone plans for essential routine vet services.
Wellness plans can help you plan and budget for the regular care your pet needs to stay happy and healthy. Taking your furry friend in for annual vet visits can help spot health problems early on, which can make treatment more manageable and help your pet avoid pain. These visits also keep your pet up to date on vaccines and preventatives, which protect them from serious illnesses in the future.
Pet wellness plan coverage details typically depend on the insurance provider and the type of plan. Wellness plans are often grouped into either basic or comprehensive coverage. While basic plans typically cover the essentials — like annual checkup fees and vaccinations — comprehensive plans tend to include a wider range of services, such as dental cleanings, supplements, and more.
Common routine care services covered by basic wellness plans:
Annual checkups
Routine diagnostics like blood, urine, and fecal tests
Vaccinations (such as rabies, DHPP, and Bordetella)
Flea, tick, and heartworm prevention
Spaying and neutering procedures
Microchipping
Comprehensive wellness plans may also include:
Dental cleanings
Dietary foods and supplements
Behavioral training
Grooming
Nail trimming
Anal gland expression
Deworming
Preventive ear cleanings
Cremation and burial
Learn more: Your guide to what pet insurance covers
Combining pet insurance with a preventive care plan can give your pet more robust coverage, helping with both unexpected illnesses or injuries and routine care like checkups and vaccines. That said, wellness plans on their own won't cover emergency trips to the vet if your pet gets hurt or sick. For example, if your dog gets sick from eating leftovers off the counter or sprains a leg while running in the yard, you'd need a pet insurance policy to help with those costs.
There are also a few things that neither type of plan typically covers, including:
Preexisting conditions with signs or symptoms showing before coverage kicked in. For example, if your pet's medical records show past issues with vomiting, that condition likely won't be covered.
Pregnancy or breeding-related costs
Cosmetic or elective procedures like claw removal or tail docking
Learn more: Pet insurance that covers preexisting conditions
Here's how pet wellness plans usually work:
You pay the vet up front for the preventive service.
You submit a claim to your pet insurance company.
The insurer reviews your claim and reimburses you for the cost, up to the limits in your plan.
Unlike standard pet insurance, which often gives you a total amount of coverage for the year, wellness plans typically come with a list of maximum reimbursement amounts for each type of service (up to the plan's overall annual limit). This means that things like vaccines, dental cleanings, and spay/neuter surgery all have their own annual coverage caps.
For example, say your wellness plan covers up to $30 per year for vaccines. If you take your dog in for a $25 rabies shot and submit a claim, you'd be reimbursed $25. You'd still have $5 left for other vaccines until the plan resets at renewal.
Pet wellness plans usually cost between $10 and $56 a month. However, the exact price you pay can depend on the company and the plan you choose. Remember that some plans may only cover the basics, while others include extra services like dental cleanings, supplements, bloodwork, and grooming.
According to Synchrony's CareCredit data from 2023–2024, a routine vet visit typically costs around $70 to $174 for dogs and $53 to $124 for cats. But just like with wellness plan costs, what you actually pay can vary. Costs typically depend on factors like where you live, the type of vet you visit (general clinic vs. specialty), and how healthy your pet is.
According to Synchrony data, here's a look at what you can expect to pay for some common routine care services for dogs and cats.
Companies that offer pet wellness plans include:
Pets Best
Embrace
Fetch
Liberty Mutual
Hartville
Lemonade
Spot
MetLife
AKC
Nationwide
Chewy
Banfield
Trupanion
ASPCA
Pumpkin
One thing to note is that the ASPCA doesn't directly provide pet insurance; instead, it partners with third-party providers, including United States Fire Insurance Company and Independence American Insurance Company, to underwrite the policies. Learn more about ASPCA pet insurance in our review.
If you're considering a pet wellness plan, it's important to understand what's included before you enroll. Most importantly, look first at the coverage in the main pet insurance policy and the cost – the details of the main policy are more important than the wellness plan add-on because the main policy will be providing the core insurance in case of an expensive accident or illness.
Learn more: The best pet insurance companies of 2025
Nonetheless, here are a couple things to look for when reviewing wellness plan options with pet vaccination coverage:
Reimbursement caps. Some wellness plans limit your reimbursement amounts for each service, like deworming or dental cleanings. While others give you a yearly allowance to use on covered preventive care. For example, Embrace pet insurance offers Wellness Rewards plans with annual limits of over $300, $500, or $700. On the other hand, AKC pet insurance sets per-service limits that add up to a total yearly cap.
Coverage details. Most wellness plans include coverage for basic services like vaccinations, checkups, and parasite prevention. But some plans go a bit further by offering coverage for things like grooming, training, or prescription supplements.
Extra perks. Some pet insurers offer added benefits in the main pet insurance policy, like multi-pet discounts and 24/7 vet helplines. These extras can help make caring for your pet a little more manageable.
Whether a pet wellness plan is worth it really comes down to your budget and your pet's specific needs. Because preventive care plays a big part in your pet's overall health and quality of life, a wellness plan can make those costs a little more manageable by breaking them into predictable monthly payments.
Learn more: Is pet insurance worth it? How to decide.
On the other hand, some plans may end up costing more than what you'd actually spend on routine care. Services like spaying, microchipping, or even flea prevention might not apply if your pet only needs them once (or not at all). If that's the case, it may make more sense to set aside money each month for expected routine vet visits.
Ultimately, if you'll use most of the services included, a wellness plan can be a helpful way to stay on top of your pet's preventive care needs. If not, budgeting on your own may be the better option.
Tim Manni edited this article.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
an hour ago
- Yahoo
Abvance Therapeutics Announces Presentation of Human Clinical Data at the 85th Scientific Sessions of the American Diabetes Association
CHICAGO, June 21, 2025 (GLOBE NEWSWIRE) -- Abvance Therapeutics, a biotechnology company developing next generation glucagon analogs and therapies to prevent hypoglycemia and improve glucose management, today announced the presentation of new human clinical data at the 85th Scientific Sessions of the American Diabetes Association (ADA), held in Chicago. The poster, titled 'Uncovering the bidirectional glucose-dependent relationship of insulin and glucagon: a meal-challenge study in patients with Type 1 diabetes,' was presented by Dr. Guillaume Kraft, Research Assistant Professor at Vanderbilt University. The study examined how insulin and glucagon behave when delivered together in a fixed ratio at mealtime in people with Type 1 diabetes. The study builds on earlier preclinical research at Vanderbilt University, where scientists observed that insulin and glucagon might interact differently depending on a person's blood sugar level. In that work, the hormones appeared to shift in dominance—insulin having a stronger effect when glucose was high, and glucagon becoming more influential when glucose was low. This human study explored whether similar patterns could be seen when the two hormones were given together in a single fixed ratio at mealtime to people with Type 1 diabetes, under closely monitored conditions. The clinical trial was led by Dr. Bruce Bode and his team at Atlanta Diabetes Associates involving 15 participants with Type 1 diabetes. The results suggested that combining glucagon with insulin at a single fixed ratio at mealtime may offer protection against hypoglycemia during the post-meal drop in blood sugar—without interfering with key metabolic processes. The combination was well tolerated and showed a favorable safety profile. 'We are grateful to Dr. Kraft and the research team at Vanderbilt, and to Dr. Bode and his team in Atlanta, for advancing this important translational work,' said Dr. David Maggs, co-founder of Abvance Therapeutics. 'This study provides early human insight into how carefully designed glucagon-insulin combinations may offer a new tool for improving the day-to-day safety of intensive insulin therapy.' The results mark the first human data evaluating fixed-ratio co-administration of insulin and glucagon in a mealtime setting and offer early support for Abvance's approach to rationally engineered glucagon analogs. 'Abvance is excited to build on this foundational work as we advance our pipeline of glucagon-based therapies designed to integrate seamlessly into real-world treatment strategies,' added Maggs. About Abvance TherapeuticsAbvance Therapeutics, Inc. is a privately held biotechnology company advancing novel glucagon-based therapies designed to integrate into the lived experience of diabetes care. Founded on research from Vanderbilt University and led by a team with expertise in diabetes therapeutics, drug development, and health technology. For more information visit Media & Investor ContactsEdward Raskined@ Veena Raoveena@ in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Yahoo
2 hours ago
- Yahoo
Whooping cough outbreaks declared in Iqaluit, Pond Inlet
There's an outbreak of whooping cough in Iqaluit and Pond Inlet, Nunavut, according to the territory's chief public health officer. The Department of Health announced the outbreaks in a pair of news releases Saturday. It said anyone can get the respiratory disease — also known as pertussis — but that the most severe cases are in children under the age of one. Though it spreads easily from person to person, the department says it's preventable by getting vaccinated. Symptoms of whooping cough include a low fever, a cough that lasts longer than a week or is followed by an unusual "whoop" sound, vomiting after coughing and coughing that is worse at night. Anyone with these symptoms is told to stay home, avoid contact with others, and to contact their local health centre. The department says whooping cough can spread from the time someone catches it — before they start coughing — until three weeks after their symptoms have started, or until they've been taking treatment for five days. The department says whooping cough can be treated with antibiotics. They're urging people to get vaccinated against the disease, but also to curb the spread with frequent hand washing, coughing into tissues or sleeves, and not sharing food, drinks, utensils or toothbrushes. Outbreaks of whooping cough that began in Kugaruuk and Naujaat in the spring were declared over last month.
Yahoo
2 hours ago
- Yahoo
UnitedHealth Group (NYSE:UNH) Announces Debt Financing Totalling US$3 Billion
UnitedHealth Group recently completed a substantial debt financing deal, raising $3 billion through the issuance of various Notes. This move comes amid a period of legal settlements, such as the $69 million ERISA case, and operational restructuring, including exploring bids for its Latin American operations. Despite these significant developments, the company's stock price remained relatively flat over the last month, reflecting broader market trends which also showed minimal movement. The dividend increase and shareholder discussions on executive compensation may have subtly influenced sentiment, but overall, these events seemed to align with the market's flat performance. UnitedHealth Group has 1 possible red flag we think you should know about. Trump has pledged to "unleash" American oil and gas and these 22 US stocks have developments that are poised to benefit. UnitedHealth Group's recent $3 billion debt financing and restructuring efforts, such as evaluating bids for its Latin American operations, are significant developments. While the near-term stock price remained relatively stable amid these changes, over the past five years, the company's total shareholder return, including dividends, was 13.61%. This reflects a steady growth trajectory, although in the last year, UnitedHealth underperformed the US Healthcare industry. The current share price sees a slight discount from the analyst consensus price target of $547.65, which is 28% higher than the present value. Despite recent legal settlements and compensation discussions, the company's aggressive push towards digital tools and Medicare adjustments might bolster future earnings and revenue. UnitedHealth's projected earnings per share and revenue growth is positioned slightly behind broader market expectations over the next few years, yet planned improvements in operational efficiencies could bridge this gap over time. Learn about UnitedHealth Group's future growth trajectory here. This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned. Companies discussed in this article include NYSE:UNH. This article was originally published by Simply Wall St. Have feedback on this article? Concerned about the content? with us directly. Alternatively, email editorial-team@ Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
